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ppARα-Mediated positive-
Feedback Loop Contributes to Cold 
exposure Memory
soaad Alfaqaan1, tomoki Yoshida1, Hiromi Imamura  1, Chihiro tsukano2, Yoshiji takemoto2 
& Akira Kakizuka1
Fluctuations in food availability and shifts in temperature are typical environmental changes 
experienced by animals. these environmental shifts sometimes portend more severe changes; e.g., 
chilly north winds precede the onset of winter. such telltale signs may be indicators for animals to 
prepare for such a shift. Here we show that HEK293A cells, cultured under starvation conditions, can 
“memorize” a short exposure to cold temperature (15 °C), which was evidenced by their higher survival 
rate compared to cells continuously grown at 37 °C. We refer to this phenomenon as “cold adaptation”. 
the cold-exposed cells retained high Atp levels, and addition of etomoxir, a fatty acid oxidation 
inhibitor, abrogated the enhanced cell survival. In our standard protocol, cold adaptation required 
linoleic acid (LA) supplementation along with the activity of Δ-6-desaturase (D6D), a key enzyme in LA 
metabolism. Moreover, supplementation with the LA metabolite arachidonic acid (AA), which is a high-
affinity agonist of peroxisome proliferator-activated receptor-alpha (PPARα), was able to underpin the 
cold adaptation, even in the presence of a D6D inhibitor. Cold exposure with added LA or AA prompted 
a surge in ppARα levels, followed by the induction of D6D expression; addition of a PPARα antagonist 
or a D6D inhibitor abrogated both their expression, and reduced cell survival to control levels. We also 
found that the brief cold exposure transiently prevents ppARα degradation by inhibiting the ubiquitin 
proteasome system, and starvation contributes to the enhancement of ppARα activity by inhibiting 
mTORC1. Our results reveal an innate adaptive positive-feedback mechanism with a PPARα-D6D-AA 
axis that is triggered by a brief cold exposure in cells. “Cold adaptation” could have evolved to increase 
strength and resilience against imminent extreme cold temperatures.
Environmental stimuli such as cold exposure or chronic dietary changes influence cellular responses, for instance, 
altered energy balance, gene expression, and composition or fluidity of lipid membranes1–6. It has previously been 
shown in various organisms that exposure to cold stimulates an increase in fat utilization7,8 and causes alterations 
in membrane fluidity through incorporation of unsaturated fatty acids into lipid membranes9,10. In addition, 
cold exposure also causes activation of the desaturase system11. A delta desturase, D6D, is a membrane-bound 
enzyme that catalyzes the synthesis of polyunsaturated fatty acids12 and is rapidly activated upon cooling11, possi-
bly to increase survivability13. Desaturation of membrane lipids to maintain cellular integrity in cold temperatures 
might be common in both plants and mammals14,15.
Energy availability is highly influential to cellular responses and may shift energy metabolism, and trigger 
alterations in gene expression. PPARα is a known master regulator of lipid metabolism and is responsible for 
stimulating increases in fat utilization through peroxisomal and mitochondrial β-oxidation16. PPARα may be 
implicated in metabolic disease models such as metabolic syndrome, dyslipidemia and diabetes17–19.
The concept of cooling as a therapeutic tool can be found both in nature and in the medical field. Hibernation 
is an example where metabolic shifts and cellular responses are altered to maintain survivability. Considerable 
attention has been paid to the benefits of Therapeutic Hypothermia (TH) as a noninvasive therapy with the 
purpose of preserving the function of systems at risk of damage by decreasing temperatures to 32–34 °C for sev-
eral days20. Previous studies have established that application of this treatment improved health outcomes in a 
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multitude of medical conditions21–25. TH has also been observed to preserve and maintain glucose levels through 
alterations in metabolism26,27, and delays pro-inflammatory cytokine production28.
Notwithstanding the standard TH therapy duration and temperature, the outcomes of an acute and drastic 
drop in temperature have not been thoroughly investigated as a potential influencer of energy levels. Greater 
understanding of the molecular mechanisms that underlie the response to cooling at the cellular level will there-
fore assist these applications.
Herein, we explore the ability of a brief and drastic shift in temperature to enhance cellular viability and 
describe a new method of cellular cooling using a water bath system, by which cells are cooled from 37 °C to 15 °C 
in approximately 2 min. We uncover novel relationships among the short cold exposure, maintenance of intra-
cellular ATP levels, mitochondrial membrane potential (MPP), and increased expression of PPARα and D6D. 
Collectively, these lead to enhanced cellular survivability.
Results
We have analyzed the effects of starvation on ATP levels and cell death in cultured cells. After 3–4 days of incu-
bation at 37 °C under starvation conditions, cell death occurred as a result of ATP depletion. However, in certain 
dishes significant numbers of cells were alive, even cultured with the same media (Supplementary Fig. 1a). After 
careful evaluation, we noticed that the dishes with live cells had been examined by microscopy at least once dur-
ing the incubation. We hypothesized that cells can react to a brief exposure to cold temperature by creating a state 
of starvation resistance. We tested various conditions and identified a treatment consisting of an exposure to 15 °C 
for approximately 2 min, performed 6 h after the initiation of starvation, to be most effective at producing sig-
nificant improvements in cell survival (Fig. 1a, Supplementary Fig. 1b). The influence of pH fluctuations during 
the treatment was negligible (Supplementary Fig. 1c,d). Multiple exposures of 2–3 × (15 °C for 2 min) at various 
time-points showed no significant increases in survival rate (Fig. 1b), indicating that the optimized condition, 
with a single 2-min exposure to 15 °C is enough to maximally protect cells against starvation.
Next, we measured intracellular ATP levels after the cold exposure and observed higher ATP levels in 
cold-exposed cells than in non-exposed cells during starvation (Fig. 1c, Supplementary Fig. 2a,b). ATP levels 
Figure 1. Cold exposure increases cell viability and maintains intracellular ATP levels and mitochondrial 
membrane potential following starvation. (a) Relative cell viability of (37 °C) and (5–25 °C) exposed cells at 
6 h after initiation of starvation (n = 3). (b) Relative cell viability of cells treated with a single cold exposure 
(15 °C) at 6 h (1x-6 h), double exposures at 6 and 12 h (2x-6, 12 h), 6 and 24 h (2x-6, 24 h), and triple exposures 
at 6, 8, and 12 h (3x-6, 8, 12 h) after initiation of starvation, or no exposure (37 °C) (n = 3). (c) Intracellular 
ATP levels measured by luciferase assays (n = 3). (d) MMP in (37 °C) and (15 °C) cells. Mean values for cells 
grown continuously in DMEM at 37 °C were set at 1. Distribution of data based on the five-number summary: 
minimum, first quartile, median, third quartile, and maximum (12 h: 15 °C, n = 20 cells; 37 °C, n = 13. 18 h: 
15 °C, n = 42; 37 °C, n = 42. 24 h: 15 °C, n = 40; 37 °C, n = 32). Assays for b were carried out at 30 h after initiation 
of starvation. Error bars represent SD. *P < 0.05, **P < 0.01 by unpaired two-tailed Student’s t-test.
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dropped by 40% in cold-exposed cells between 12–36 h, in contrast to a 75% drop in non-exposed cells (Fig. 1c). 
Mitochondria are crucial for ATP production, and changes in the MMP are reflective of cell health29. Thus, we 
next examined MMP using TMRM staining (Supplementary Fig. 2e)30. Consistent with the ATP levels, MMP 
levels in cold-exposed cells showed only a 14% decline at 18 h after cold exposure, whereas non-exposed cells 
experienced a 35% decline over the same time period (Fig. 1d, Supplementary Fig. 2e). Our starvation media 
(SM) contains only linoleic acid (LA) as a nutrient, and removal of LA abrogated the enhanced cell survival 
of cold-exposed cells (Fig. 2a). Treatment with etomoxir, a mitochondrial β-oxidation inhibitor, decreased the 
enhanced cell survival of cold-exposed cells to levels of non-exposed cells (Fig. 2b).
In addition to its potential as an energy source, LA metabolism yields several metabolites that serve important 
biological roles31. In this process, D6D is the rate-limiting enzyme responsible for metabolizing LA32. Thus, we 
investigated whether LA metabolites are involved in the cold adaptation. To this end, we applied SC-26196, a 
specific inhibitor of D6D33. Addition of the inhibitor to cold-exposed cells ablated the enhanced cell survival in 
a dose-dependent manner (Fig. 2c), as well as abrogated the effects of cold exposure for maintaining ATP levels 
(Fig. 2d, Supplementary Fig. 2c,d).
Surprisingly, expression of D6D was not detected in cells cultured in normal medium. We therefore inves-
tigated the regulation of its expression in response to cold exposure under LA supplementation. Western blot 
analysis revealed the induction of D6D expression in cold-exposed cells, with substantial expression observed at 
4 h, and continued expression up to 24 h post-cold. In sharp contrast, D6D was not detected in non-exposed cells 
(Fig. 3a). To confirm D6D activity, we performed Fatty Acid Methyl Ester (FAME) analysis of lipid components by 
GC-MS of cold-exposed and non-exposed samples to compare the profiles of the chromatograms. FAME analysis 
revealed a large disparity between cold-exposed and non-exposed cells (Fig. 3b). Inhibition of D6D by SC-26196 
in cold-exposed cells altered the chromatogram, rendering it like that of non-exposed cells (Fig. 3b). These results 
further support the notion that cold exposure induces D6D activity, thereby favoring LA metabolism.
Arachidonic acid (AA) is an LA metabolite with various biological functions34–37. We next investigated 
whether AA is involved in cold adaptation. Supplementation with AA recapitulated the cold-induced survival, 
even when D6D activity was inhibited (Fig. 3c), implying that the major role of D6D in cold adaptation is to 
produce AA. Among the known functions of AA38,39, we speculated that in cold adaptation it acts as an ago-
nistic ligand for PPARα. PPARα is a master regulator of fatty acid (FA) metabolism17,40, and it induces genes 
specific for lipid metabolism, including D6D41–43. Somewhat surprisingly, PPARα was not detected in normal 
culture and starvation conditions at 37 °C. However, we observed PPARα expression from 1 h after the cold expo-
sure, with subsequent D6D expression (Fig. 3a). By contrast, we observed steady-state, constitutive expression of 
Figure 2. Linoleic acid supplementation along with D6D activity is required for enhanced cell viability and 
intracellular ATP maintenance (a) Dose response of LA supplementation on cell viability of non-exposed 
(37 °C) and cold-exposed (15 °C) cells (n = 3). (b) Viability of (15 °C) or (37 °C) cells treated with or without 100 
μM etomoxir. (c) Dose response of SC-26196 on cell viability of (37 °C) and (15 °C) cells (n = 3). (d) Intracellular 
ATP levels measured by luciferase assays of (37 °C) and (15 °C) cells treated with 2 μM SC-26196 (15 °C + SC-
26196) (n = 3). Assays for (a–c) were carried out at 30 h after initiation of starvation. Error bars represent SD. 
*P < 0.05, **P < 0.01 by unpaired two-tailed Student’s t-test.
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peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), a coactivator or a protein ligand 
of PPARα44,45, in both cold-exposed and non-exposed cells (Fig. 3a). These results suggest that cold exposure pri-
marily raises the PPARα protein level, promoting its activation through binding to PGC1α19. Activated PPARα 
in turn would induce D6D expression, leading to the production of AA, further activating PPARα. Consistent 
with this notion, application of a PPARα antagonist (GW6471) eliminated the expression of D6D along with the 
cold-induced survival (Fig. 3d,e, Supplementary Fig. 3a). Treatment with a PPARα agonist (WY14643) induced 
both PPARα and D6D expression, even without cold exposure (Fig. 3e, Supplementary Fig. 3a). In the presence of 
LA, we observed continuously increasing PPARα expression along with subsequent D6D induction after the cold 
exposure (Fig. 3a), however, this pattern was not observed in the absence of LA (Fig. 3f, Supplementary Fig. 3b). 
More interestingly, inhibition of D6D activity eliminated both D6D and PPARα expressions in cold-exposed cells 
(Fig. 3g, Supplementary Fig. 3c). Together, these results point to a positive-feedback mechanism between PPARα 
and D6D. It is interesting to note that HepG2 cells, derived from a human hepatocellular carcinoma, showed 
constitutive expression of both PPARα and D6D (Fig. 3a), which is not unexpected in cells that retain many 
liver-specific characteristics, including fat metabolism.
PPARα is readily degraded by the ubiquitin proteasome system (UPS)46,47. Therefore, we examined PPARα 
levels in cells treated with MG132, a proteasome inhibitor, and observed sustained PPARα expression in both 
cold-exposed and non-exposed cells (Fig. 4a), confirming that constitutively translated PPARα is continu-
ously degraded by the UPS. In addition to PPARα expression, D6D expression was also evident in cells treated 
with MG132 (Fig. 4a), along with downstream FA metabolites, reflecting the presence of D6D activity even in 
MG132-treated cells maintained at 37 °C (Fig. 4b). Thus, inhibition of PPARα degradation in non-exposed cells 
replicates the cold adaptation profile.
We then speculated that cold exposure interferes with the UPS. Indeed, we found a dramatic decrease in 
the accumulation of ubiquitinated proteins in cold-exposed cells compared to the non-exposed cells (Fig. 4c). 
Conversely, overexpression of ubiquitin increased the accumulation of ubiquitinated proteins, even in 
cold-exposed cells (Fig. 4c), eliminated PPARα and D6D expression in cold-exposed cells (Fig. 4d), and abro-
gated the cold-induced survival (Fig. 4e).
Figure 3. PPARα and D6D activities are essential for cold-induced survival. (a) PGC1α, PPARα, and 
D6D expression at various time points in (37 °C) and (15 °C) cells (n = 3). Blots for PGC1α and Actin 
were derived from the same gel, and blots for PPARα and D6D were derived from individual gels. Blots for 
individual proteins were generated using the same samples. (b) FAME analyses by GC-MS of (15 °C), (37 °C), 
(15 °C + 2 μM SC-26196), and cells in high glucose DMEM supplemented with 10 μM LA (n = 3). (c) Influence 
of FA supplementation on cell viability of (37 °C) and (15 °C) cells supplemented with 10 μM LA; 10 μM LA + 2 
μM SC-26196; 10 μM LA + 10 μM AA + 2 μM SC-26196; and 10 μM AA (n = 3). (d,e) Effects of PPARα agonist 
(10 μM WY14643) or antagonist (1 μM GW6471) on cell viability (d) and PPARα and D6D expression levels 
(e) in (37 °C) and (15 °C) cells (n = 3). (f) PPARα and D6D expression at various time points without LA 
supplementation in (37 °C) and (15 °C) cells (n = 3). (g) Influence of FA supplementation on PPARα and D6D 
expression in (37 °C) and (15 °C) cells supplemented with 10 μM LA; 10 μM LA + 2 μM SC-26196; 10 μM AA 
(n = 3). Error bars represent SD. *P < 0.05, **P < 0.01 by unpaired two-tailed Student’s t-test. For gel source 
data, see Supplementary Fig. 4.
5Scientific RepoRts |          (2019) 9:4538  | https://doi.org/10.1038/s41598-019-40633-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
Consistently, cold-exposed cells overexpressing ubiquitin displayed no increase in FA metabolites (Fig. 4b). 
These results clearly indicate that cold exposure inhibits UPS activity, preventing PPARα degradation. Note that 
a decrease in ubiquitinated proteins was also observed in cells cultured in DMEM and exposed to cold (Fig. 4c), 
demonstrating that the ability of a cold exposure to inhibit the UPS is not dependent on a specific nutrient profile.
Cold exposure-induced PPARα and D6D expression was observed under DMEM glucose (−)/LA (+), but 
not in DMEM glucose (+)/LA (+), glucose (+)/LA (−), or glucose (−)/LA (−) at 24 h post-cold (Supplementary 
Fig. 4d). Closer investigation revealed that PPARα and subsequent D6D expression in DMEM glucose (−)/LA 
(+) were time-dependent (Fig. 5a). Surprisingly, a transient PPARα expression was detected even in DMEM glu-
cose (+)/LA (+) at only 1 h post-cold (Fig. 5b). D6D, however, was not detected in this condition, implying that 
continuous expression as well as activation of PPARα does not occur under glucose (+) conditions.
A previous study revealed that the inhibition of the mammalian target of rapamycin 1 (mTORC1) is required 
for the activation of PPARα48. The activation of mTORC1 is influenced by nutrients such as glucose49,50, and 
triggers cellular responses by phosphorylating p70 S6 kinase51 at threonine 389, indicated as (phospho-p70 S6 
Kinase) (Fig. 5c,d). Consistent with this data, addition of Torin-1, an mTORC1 inhibitor, even in DMEM glucose 
(+) led to clear PPARα and D6D expression after cold exposure (Fig. 5c). Furthermore, glucose doses ranging 
from 0 to 450 mg/dL showed an inverse relationship between PPARα and S6K phosphorylation levels. Although 
PPARα and D6D expression was not observed under the high glucose condition (450 mg/dL), both expressions 
were observed at relatively low glucose concentrations, up to 100 mg/dL glucose, after cold exposure (Fig. 5d).
Discussion
Herein, we have uncovered an intricate regulatory relationship between an acute cold exposure and an increase 
in PPARα gene expression mediated through a PPARα-D6D-AA positive-feedback loop. During this study cold 
exposure appears to be initially sensed by the UPS and results in its inhibition, which leads to PPARα stabiliza-
tion46. PPARα then transcriptionally activates genes involved in lipid metabolism, including D6D to produce 
AA, which further activates PPARα as its high affinity ligand. This gives rise to a positive-feedback loop between 
PPARα, D6D, and AA. This feedback loop continuously activates lipid metabolism, which is demonstrated by the 
maintained MPP levels to produce ATP. We refer to this phenomenon as “cold adaptation.” Furthermore, our data 
Figure 4. Cold exposure induces PPARα expression through inhibition of the UPS. (a) PPARα and D6D 
expression under treatment with 20 μM MG132. MG132 was added 6 h after initiation of starvation. (n = 3). 
(b) FAME analyses of (15 °C) or (37 °C) cells overexpressing ubiquitin. To determine the UPS involvement, 
cells were treated with 20 μM MG132 for 12 h before collection (n = 3). (c) Ubiquitination of proteins in 
untransfected cells (Non-ovx), cells overexpressing vector (Vec-ovx), or overexpressing ubiquitin (Ub-ovx). 
All cells were treated with 20 μM MG132 at 12 h before collection (n = 3). (d) PPARα and D6D expression in 
untransfected cells, cells overexpressing vector (Vec-ovx), and cells overexpressing ubiquitin (Ub-ovx) (n = 3). 
(e) Influence of ubiquitin overexpression on cell viability in (15 °C) or (37 °C) cells (n = 3). Assays for (c–e) were 
carried out at 18 h after initiation of starvation. Blots for PPARα, D6D, Actin, and ubiquitin were derived from 
individual gels, using aliquots of the same samples. Error bars represent SD. *P < 0.05, **P < 0.01 by unpaired 
two-tailed Student’s t-test. For gel source data, see Supplementary Fig. 4.
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suggest that starvation further enhances this positive-feedback loop, as the presence of high amounts of glucose 
attenuates PPARα and D6D expression, and inhibition of mTORC1 was able to reverse this.
Cold exposure results in enhanced cellular dynamics14 and is associated with modulation of cell metabolism, 
gene expression, and cellular ATP levels52–54. Here we confirm these observations showing that, after cold expo-
sure of cells to 15 °C for approximately 2 min, 6 h post starvation, cells do indeed modulate their metabolism and 
are capable of withstanding starvation under LA or AA supplementation. Single and multiple cold exposures lead 
to similar outcomes, indicating that this single exposure is fully capable of eliciting the cold exposure response 
in cells.
Adaptation is a fundamental survival strategy for organisms to cope with environmental changes and is most 
typically associated with neurons and the sympathetic nervous system. In this study we found that “cold adapta-
tion” is a more fundamental type of cellular adaptation. HEK293A cells in culture acquire a quasi-stable cellular 
metabolic state that may be considered a form of cellular memory. In response to a brief exposure to cold in this 
case, this cellular “memory” sustained by a positive-feedback loop enhances cell viability and supports the notion 
of a fundamental type of cellular adaptation.
While the PPARα-D6D axis has been implicated under various environmental conditions, implication of the 
UPS by cold exposure leading to the enhancement of PPARα accumulation and activation has not previously 
been reported. The UPS regulates a multitude of systems. Hence, identifying and understanding the influencers 
of its activity can contribute to our general knowledge of the UPS itself and its controlling systems, such as cold 
adaptation. In addition, our data illustrates the presence of a PPARα-D6D-AA positive-feedback mechanism that 
is triggered by a brief cold exposure. This system may be utilized by mammals in cold seasons or hibernation, 
in which food is expected to be limited, and in which lipid metabolism is the primary source of fuel. It might 
be interesting to examine cells from such mammals to further investigate the mechanism driving resilience of 
cellular metabolic states.
Materials and Methods
Materials and Reagents. Materials, reagents, and vendors are as follows:
Dulbecco’s modified Eagle’s medium (DMEM), phenol red-free DMEM, and phosphate buffer saline (−) 
(PBS) (Nacalai Tesque, Kyoto, Japan); Earle’s balanced salt solution without glucose (EBSS) (prepared in our 
Figure 5. PPARα and D6D are not detectable under high glucose conditions. (a,b) Expression levels of 
PGC1α, PPARα, and D6D at various time points in (37 °C) and (15 °C) cells in DMEM without (a) and with 
(b) glucose (n = 3). (c) PPARα and D6D expression in (37 °C) and (15 °C) cells treated in DMEM ±glucose 
and ±1 μM Torin-1 (mTORC1 inhibitor). Torin-1 was added 24 h prior to collection, and cold exposed cells 
were treated at 18 h prior to collection (n = 3). Phospho-p70 S6 Kinase (Thr-389) represents phosphorylated 
S6 kinase at threonine 389 indicating mTORC1 activity, and p70 S6 kinase demonstrates endogenous levels of 
S6 kinase. (d) PPARα and D6D expression under varying doses of glucose (0–450 mg/dL) in (15 °C) or (37 °C) 
cells. Assays were carried out at 24 h after glucose deprivation (n = 3). (a,b) Blots for PGC1α and Actin were 
derived from the same gel, and PPARα and D6D were derived from individual gels, using aliquots of the same 
samples. (c,d) Blots were derived from individual gels, using aliquots of the same samples. Error bars represent 
SD. For gel source data, see Supplementary Fig. 4.
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lab according to the recipe from Nacalai Tesque); fetal bovine serum (FBS) (Sigma, St. Louis, MO, USA); lin-
oleic acid sodium salt (Nacalai Tesque); arachidonic acid sodium salt (Nacalai Tesque); penicillin/streptomycin 
mixed solution (Nacalai Tesque); fatty acid free bovine serum albumin (Nacalai Tesque); cell count reagent SF 
(Nacalai Tesque); Glo-Lysis buffer (Promega Corporation, Madison, WI, USA); luciferase-based ATP assay kit 
(Toyo B-Net, Tokyo, Japan); 35 mm glass-bottom dishes (Mattek, Ashland, MA, USA); MitoTracker Green FM 
and Tetramethylrhodamine, ethyl ester (TMRE) (Invitrogen, Carlsbad, CA, USA); Protein Assay Bicinchoninate 
Kit (Nacalai Tesque); HEPES (Dojindo, Japan); WY14647, GW6471, MG132, and etomoxir sodium salt (Cayman 
Chemical, USA); Fatty acid methyl ester mix (Sigma); Fatty acid methyl ester purification kit (06483) and fatty 
acid ester methylation kit (06482) (Nacalai Tesque); Torin-1 (Funakoshi, Japan); SuperSep Ace 5–20% (Wako, 
Osaka, Japan); Collagen Type IC (Cellmatrix, WAKO, Japan); SDS, 0.5% sodium deoxycholate (Nacalai Tesque) 
supplemented with 1 mM sodium disphosphate decahydrate, 1 mM NaF, 0.5 mM PMSF, 1 mM NaVO4, 1 × pro-
tease inhibitor cocktail (Nacalai Tesque), 10 mM β-glycerophosphate (Sigma), and 0.1% CHAPS (Dojindo, 
Kumamoto, Japan); a Protein Assay Bicinchoninate Kit (Nacalai Tesque); Lipofectamine 2000 (Life Technologies, 
Grand Island, NY); polyvinylidene difluoride (PVDF) membranes (Millipore, Billerica, MA, USA). All chemicals 
used were of analytical grade and were used as received without any further purification. All solutions were pre-
pared with deionized water.
Antibodies. Antibodies to phospho-p70 S6 kinase (Thr389) (9234), and p70 S6 kinase (9202) were purchased 
from Cell Signaling Technology (Danvers, MA, USA); the antibody to PGC1α (NBP1-0467622) was purchased 
from NovusBio (Littleton CO, USA); the antibody to D6D (ab170665) was purchased from Abcam; the antibody 
against PPARα (sc-9000) was purchased from Santa Cruz Biotech; antibodies against actin (MAB1501), and 
against ubiquitin (MAB1510) were purchased from EMD Millipore (Temecula, CA, USA). HRP-labeled second-
ary antibodies (GE Healthcare UK Ltd., Buckinghamshire, England) were used for visualization by enhanced 
chemiluminescence.
Cells and Cell Culture. We established HEK293A cells continuously expressing ATeam-1.0355,56 
(HEK293A-ATeam-1.03 cells). HEK293A and HEK293A-ATeam-1.03 cells were cultured and maintained in high 
glucose (450 mg/dL) DMEM, and HepG2 in low glucose (100 mg/dL) DMEM. Cell cultures were supplemented 
with 10% FBS and maintained at 37 °C and 5% CO2.
starvation and Cold exposure. HEK293A cells were plated on 10 cm dishes (FPI, Japan) at a density of 
10,000 cells/cm2 in high glucose DMEM, supplemented with 10% FBS. After 24 h, cells were gently washed twice 
with PBS, and then incubated in starvation medium (SM), composed of EBSS supplemented with 20 mM HEPES 
(pH 7.5), 10 μM linoleic acid sodium salt, 100 unit/mL penicillin, 100 μg/mL streptomycin, and 0.5% fatty acid 
free-BSA. After 6 h incubation period in SM, cells were removed from the incubator and directly placed on a 
cold-water bath. The temperature of the medium in the dish was monitored using a thermometer. After approxi-
mately 2 min on the water bath, the medium reached the desired temperature (15 °C) and the plate was immedi-
ately placed back into the incubator.
Cell Viability Assays. Cell viability of HEK293A cells was determined using SF cell-counting reagent accord-
ing to the manufacturer’s instructions (Nacalai Tesque). Measurements were carried out using a plate reader 
(ARVO multi-label counter, Perkin Elmer, Inc.). Cell viability was calculated as the ratio of treated cells divided 
by cells cultured in DMEM at 37 °C for 24 h. Cell viability was measured from independent trials.
Atp Luciferase Assay. Intracellular ATP levels of HEK293A cells were determined according to the follow-
ing protocol with slight modifications. Briefly, duplicate dishes were prepared for each individual sample, one for 
the ATP measurement, and one for cell count. For the ATP measurements, cells were lysed with Glo-lysis buffer 
for 5 min on ice after washing two times with pre-cooled PBS. ATP amount in the lysate was measured with a 
luciferase-based ATP assay kit (Toyo B-net). ATP measurements were obtained using a luminometer (ARVO 
multi-label counter), and the cell count was determined using a cell counter (countess II FL, Life technologies). 
ATP/cell values were calculated by dividing the total ATP amount in the lysate by the total cell number. ATP levels 
were measured from three independent trials.
Imaging of Intracellular Atp Levels. HEK293A-ATeam-1.03 cells were plated at a density of 10,000 
cells/cm2 on a 35 mm collagen-coated glass-bottom dish, in phenol red-free DMEM, and the starvation and cold 
exposure were performed as described above. Imaging was carried out as previously described55 using a Nikon 
Ti-E-PFS inverted microscope equipped with the following filter sets (Semrock, Rochester, NY) for dual emission 
ratio imaging, 438/24-DM458, 483/32 (CFP) or 542/27 (YFP) and a 40x objective (Nikon, Tokyo, Japan; CFI Plan 
Apo λ 40x: NA 0.95). Data were analyzed using MetaMorph analysis software (Molecular Devices, Sunnyvale, 
CA, USA). The YFP/CFP emission ratio was calculated by dividing YFP intensity by CFP intensity for each cell. 
ATP levels were measured from independent trials.
Measurement of Mitochondrial Membrane potential. Mitochondrial membrane potential (MMP) 
using HEK293A cells was measured according to the previous report30. HEK293A cells were plated on a 35 mm 
collagen-coated glass-bottom dish in phenol red-free DMEM, and the starvation and cold exposure were per-
formed as described above. Cells were treated with 50 nM MitoTracker Green and 50 nM TMRM for 30 min 
at 37 °C. After washing out with pre-warmed phenol red-free starvation medium, imaging was carried out for 
measurement of florescent intensity of MitoTracker Green and TMRM from individual cells in phenol red-free 
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starvation medium. MMP per cell was calculated by dividing the average intensities of TMRM by mitochondrial 
area as determined by signals from Mitotracker Green. Data were analyzed using MetaMorph analysis software. 
MMP was determined from cells of three independent trails.
Western Blot Analysis. Cells were collected and lysed in RIPA buffer (150 mM NaCl, 1% NP40, 50 mM 
Tris-HCl (pH 7.6), 0.1% SDS, 0.5% sodium deoxycholate supplemented with 1 mM sodium disphosphate dec-
ahydrate, 1 mM NaF, 0.5 mM PMSF, 1 mM NaVO4, 1 × protease inhibitor cocktail 10 mM β-glycerophosphate, 
and 0.1% CHAPS. After sonication of the lysate on ice, the supernatant was collected by centrifugation at 4 °C at 
15,000 rpm for 15 min. The protein content in the lysate was measured using a Protein Assay Bicinchoninate Kit 
(Nacalai Tesque), following the manufacturer’s instructions. Protein samples (35 μg) were prepared, loaded, and 
separated on SuperSep Ace 5–20% precast gels (Wako), and transferred onto polyvinylidene difluoride (PVDF) 
membranes (Millipore, Billerica, MA, USA). Western blot analysis detecting ubiquitin was carried out on a 15% 
gel.
For western blot analysis of PPARα expression, minimal expression of PPARα was detected in HEK293A cells, 
therefore, we overexpressed PPARα to fully visualize the capacity of cold exposure on enhancing PPARα expres-
sion (Supplementary Fig. 3e). Samples taken from three independent trails. For western blot analysis of PPARα, 
HEK293A(PPARα) were used, and control cells (HEK293A and HepG2) cultured in DMEM at 37 °C were har-
vested 24 h after seeding. Relative protein expression levels were normalized to actin. Values for HepG2 cells were 
set at 1. Unless specified otherwise, western blot samples were collected 30 h after initiation of starvation.
Samples in Figs 3a,c,d,e, 4a,c,d, and 5 were all supplemented with 10 µM LA, and samples in Fig. 3f were not 
supplemented with LA.
Fatty Acid Methyl Ester (FAME) Composition Analysis. GC analysis using electron capture detec-
tion was used to characterize the FA composition of cell samples. FA extraction was carried out according to 
this report57. Briefly, 18 h after the initiation of starvations, HEK293A cells were pelleted by centrifugation at 
7,500 rpm for 5 min at 4 °C. Lipids were then extracted by addition of 600 μL cold acetone followed by three 
rounds of vortexing for 1 min each, freezing with liquid nitrogen, and ultrasonication for 5 min. Cells were then 
incubated at −20 °C for 1 h, followed by centrifugation at 15,000 rpm at 4 °C for 15 min. The supernatant was 
collected into a fresh tube and placed on ice. The pellet is resuspended in 400 μL of methanol: water: formic 
acid (86.5:12.5:1.0), followed by vortexing for 1 min, and 10 min of ultrasonication in a water bath. The sample 
was placed at −20 °C for 1 h, followed by centrifugation at 15,000 rpm at 4 °C for 15 min. The supernatant was 
collected and combined with the supernatant from the first extraction. The sample was dried under nitrogen fol-
lowed by methylation and purification using a FA methylation kit, and FA purification kit, respectively (Nacalai 
Tesque), according to manufacturer’s protocol. The sample was injected at a concentration of 1 mg/mL into a 
GC-MS system consisting of a GCMS-QP2010/Parvum2 (Shimadzu) attached to a DB-5 MS column (Agilent 
technologies). The flow rate of the Helium gas as a carrier was 1.25 mL/min. Samples taken from three independ-
ent trails.
transfection. HEK293A cells were cultured in 10 cm dishes in DMEM supplemented with 10% FBS and incu-
bated at 37 °C for 24 h. The total amount of DNA in each transfection was adjusted to 7.0 μg/dish for pcDNA3.1 
FLAG-ubiquitin, and 10.5 μg/dish for vector (pcDNA3.1(−)), and pLXSN PPARα-5974. Co-transfections were 
performed simultaneously with the DNA concentrations. Transfections were performed using Lipofectamine 
2000 (Life Technologies, Grand Island, NY) according to the manufacturer’s recommendations.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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